CVS HEALTH Corp Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
CVS HEALTH Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q4 2023.
  • CVS HEALTH Corp Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $385M, a 27.6% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $385M -$147M -27.6% Dec 31, 2023 10-K 2024-02-07
Q4 2022 $532M +$207M +63.7% Dec 31, 2022 10-K 2024-02-07
Q4 2021 $325M -$129M -28.4% Dec 31, 2021 8-K 2023-05-25
Q4 2020 $454M +$80M +21.4% Dec 31, 2020 10-K 2022-02-09
Q4 2019 $374M -$146M -28.1% Dec 31, 2019 10-K 2021-02-16
Q4 2018 $520M +$443M +575% Dec 31, 2018 10-K 2020-02-18
Q4 2017 $77M -$58M -43% Dec 31, 2017 8-K 2019-08-08
Q4 2016 $135M +$20M +17.4% Dec 31, 2016 10-K 2018-02-14
Q4 2015 $115M +$110M +2200% Dec 31, 2015 10-K 2017-02-09
Q4 2014 $5M +$2M +66.7% Dec 31, 2014 10-K 2016-02-09
Q4 2013 $3M +$3M Dec 31, 2013 10-K 2015-02-10
Q4 2012 $0 Dec 31, 2012 10-K 2014-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.